{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:59:52Z","timestamp":1794646792577,"version":"4.9.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T00:00:00Z","timestamp":1548374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006442","name":"University of Copenhagen | Det Sundhedsvidenskabelige Fakultet, K\u00f8benhavns Universitet","doi-asserted-by":"publisher","award":["R131-A5521"],"award-info":[{"award-number":["R131-A5521"]}],"id":[{"id":"10.13039\/501100006442","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1038\/s41409-018-0426-8","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T16:02:40Z","timestamp":1548432160000},"page":"1406-1418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Assessment of the proposed EBMT pediatric criteria for diagnosis and severity grading of sinusoidal obstruction syndrome"],"prefix":"10.1038","volume":"54","author":[{"given":"Marte B.","family":"Kammersgaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrine","family":"Kielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Heilmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Ifversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,25]]},"reference":[{"key":"426_CR1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jceh.2014.10.002","volume":"4","author":"CQ Fan","year":"2014","unstructured":"Fan CQ, Crawford JM. Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). J Clin Exp Hepatol. 2014;4:332\u201346. \n                    https:\/\/doi.org\/10.1016\/j.jceh.2014.10.002","journal-title":"J Clin Exp Hepatol"},{"key":"426_CR2","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/bmt.2011.65","volume":"46","author":"E Carreras","year":"2011","unstructured":"Carreras E, Diaz-Ricart M. The role of the endothelium in the short-term complications of hematopoietic SCT. Bone Marrow Transplant. 2011;46:1495\u2013502. \n                    https:\/\/doi.org\/10.1038\/bmt.2011.65","journal-title":"Bone Marrow Transplant"},{"key":"426_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","volume":"16","author":"JA Coppell","year":"2010","unstructured":"Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A, et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant. 2010;16:157\u201368. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2009.08.024","journal-title":"Biol Blood Marrow Transplant"},{"key":"426_CR4","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/bmt.2015.52","volume":"50","author":"M Mohty","year":"2015","unstructured":"Mohty M, Malard F, Abecassis M, Aerts A, Alaskar AS, Aljurf M, et al. Sinusoidal obstruction syndrome\/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2015;50:781\u20139. \n                    https:\/\/doi.org\/10.1038\/bmt.2015.52","journal-title":"Bone Marrow Transplant"},{"key":"426_CR5","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","volume":"379","author":"S Corbacioglu","year":"2012","unstructured":"Corbacioglu S, Cesaro S, Faraci M, Valteau-Couanet D, Gruhn B, Rovelli A, et al. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial. Lancet. 2012;379:1301\u20139. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(11)61938-7","journal-title":"Lancet"},{"key":"426_CR6","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1182\/blood-2015-10-676924","volume":"127","author":"PG Richardson","year":"2016","unstructured":"Richardson PG, Riches ML, Kernan NA, Brochstein JA, Mineishi S, Termuhlen AM, et al. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. Blood. 2016;127:1656\u201366. \n                    https:\/\/doi.org\/10.1182\/blood-2015-10-676924","journal-title":"Blood"},{"issue":"2","key":"426_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/bmt.2017.161","volume":"53","author":"S Corbacioglu","year":"2017","unstructured":"Corbacioglu S, Carreras E, Ansari M, Balduzzi A, Cesaro S, Dalle JH, et al. Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transplant. 2018;53:138\u201345. \n                    https:\/\/doi.org\/10.1038\/bmt.2017.161\n                    \n                  .","journal-title":"Bone Marrow Transplantation"},{"key":"426_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/sj.bmt.1704069","volume":"32","author":"CC Barker","year":"2003","unstructured":"Barker CC, Butzner JD, Anderson RA, Brant R, Sauve RS. Post-transplant complications incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2003;32:79\u201387. \n                    https:\/\/doi.org\/10.1038\/sj.bmt.1704069","journal-title":"Bone Marrow Transplant"},{"key":"426_CR9","first-page":"1396","volume":"90","author":"S Cesaro","year":"2005","unstructured":"Cesaro S, Pillon M, Talenti E, Toffolutti T, Calore E, Tridello G, et al. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Haematologica. 2005;90:1396\u2013404.","journal-title":"Haematologica"},{"key":"426_CR10","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/sj.bmt.1705835","volume":"40","author":"D Cheuk","year":"2007","unstructured":"Cheuk D, Wang P, Lee TL, Chiang AK, Ha SY, Lau YL, et al. Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation. Bone Marrow Transplant. 2007;40:935\u201344. \n                    https:\/\/doi.org\/10.1038\/sj.bmt.1705835","journal-title":"Bone Marrow Transplant"},{"key":"426_CR11","first-page":"3599","volume":"92","author":"E Carreras","year":"1998","unstructured":"Carreras E, Bertz H, Arcese W, Vernant JP, Tom\u00e1s JF, Hagglund H, et al. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. Blood. 1998;92:3599\u2013605.","journal-title":"Blood"},{"key":"426_CR12","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/bjh.12558","volume":"163","author":"FL Dignan","year":"2013","unstructured":"Dignan FL, Wynn RF, Hadzic N, Karani J, Quaglia A, Pagliuca A, et al. BCSH\/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. Br J Haematol. 2013;163:444\u201357. \n                    https:\/\/doi.org\/10.1111\/bjh.12558","journal-title":"Br J Haematol"},{"key":"426_CR13","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/sj.bmt.1705485","volume":"38","author":"S Corbacioglu","year":"2006","unstructured":"Corbacioglu S, H\u00f6nig M, Lahr G, St\u00f6hr S, Berry G, Friedrich W, et al. Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD, which could be prevented with defibrotide. Bone Marrow Transplant. 2006;38:547\u201353. \n                    https:\/\/doi.org\/10.1038\/sj.bmt.1705485","journal-title":"Bone Marrow Transplant"},{"key":"426_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.1840040121","volume":"4","author":"GB McDonald","year":"1984","unstructured":"McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Venoocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology. 1984;4:116\u201322.","journal-title":"Hepatology"},{"key":"426_CR15","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG, et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation. 1987;44:778\u201383.","journal-title":"Transplantation"},{"key":"426_CR16","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/sj.bmt.1701994","volume":"24","author":"HC Toh","year":"1999","unstructured":"Toh HC, Mcafee SL, Sackstein R, Cox BF, Colby C, Spitzer TR. Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation. Bone Marrow Transplant. 1999;24:891\u20135.","journal-title":"Bone Marrow Transplant"},{"key":"426_CR17","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1200\/JCO.1993.11.9.1729","volume":"11","author":"SI Bearman","year":"1993","unstructured":"Bearman SI, Anderson GL, Mori M, Hinds MS, Shulman HM, Mcdonald GB. Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. J Clin Oncol. 1993;11:1729\u201336.","journal-title":"J Clin Oncol"},{"key":"426_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/bmt.2015.208","volume":"51","author":"JC Naples","year":"2015","unstructured":"Naples JC, Skeens MA, Auletta J, Rangarajan H, Abu-Arja R, Horowitz E, et al. Anicteric veno-occlusive disease after hematopoietic stem cell transplantation in children. Bone Marrow Transplant. 2015;51:135\u20137. \n                    https:\/\/doi.org\/10.1038\/bmt.2015.208","journal-title":"Bone Marrow Transplant"},{"key":"426_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","volume":"118","author":"G Mcdonald","year":"1993","unstructured":"Mcdonald G, Hinds M, Fisher L, Schoch H, Wolford J, Banaji M, et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med. 1993;118:255\u201367.","journal-title":"Ann Intern Med"},{"key":"426_CR20","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1365-2141.2008.07189.x","volume":"142","author":"E Hod","year":"2008","unstructured":"Hod E, Schwartz J. Platelet transfusion refractoriness. Br J Haematol. 2008;142:348\u201360. \n                    https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07189.x","journal-title":"Br J Haematol"},{"key":"426_CR21","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1182\/blood.V67.6.1773.1773","volume":"6","author":"B Rio","year":"1986","unstructured":"Rio B, Andreu G, Nicod A, Arrago J, Dutrillaux F, Samama M, et al. Thrombocytopenia in venoocclusive disease after bone marrow transplantation or chemotherapy. Blood. 1986;6:1773\u20136.","journal-title":"Blood"},{"key":"426_CR22","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","volume":"100","author":"PG Richardson","year":"2002","unstructured":"Richardson PG, Murakami C, Jin Z, Warren D, Momtaz P, Hoppensteadt D, et al. Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome. Blood. 2002;100:4337\u201343. \n                    https:\/\/doi.org\/10.1182\/blood-2002-04-1216","journal-title":"Blood"},{"key":"426_CR23","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1016\/j.bbmt.2016.07.001","volume":"22","author":"S Corbacioglu","year":"2016","unstructured":"Corbacioglu S, Carreras E, Mohty M, Pagliuca A, Boelens JJ, Damaj G, et al. Defibrotide for the treatment of hepatic veno-occlusive disease: final results from the International Compassionate-Use Program. Biol Blood Marrow Transplant. 2016;22:1874\u201382. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2016.07.001","journal-title":"Biol Blood Marrow Transplant"},{"key":"426_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.bmt.1704329","volume":"33","author":"S Corbacioglu","year":"2004","unstructured":"Corbacioglu S, Greil J, Peters C, Wulffraat N, Laws HJ, Dilloo D, et al. Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transplant. 2004;33:189\u201395. \n                    https:\/\/doi.org\/10.1038\/sj.bmt.1704329","journal-title":"Bone Marrow Transplant"},{"key":"426_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/bjh.14727","volume":"178","author":"PG Richardson","year":"2017","unstructured":"Richardson PG, Smith AR, Triplett BM, Kernan NA, Grupp SA, Antin JH, et al. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease\/sinusoidal obstruction syndrome improves Day+100 survival following haematopoietic stem cell transplantation. Br J Haematol. 2017;178:112\u20138. \n                    https:\/\/doi.org\/10.1111\/bjh.14727","journal-title":"Br J Haematol"},{"key":"426_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BF01695888","volume":"13","author":"E Carreras","year":"1993","unstructured":"Carreras E, Grafiena A, Navasa M, Bruguera M, Marco V, Sierra J, et al. On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease. Ann Hematol. 1993;13:77\u201380.","journal-title":"Ann Hematol"},{"key":"426_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/sji.12244","volume":"81","author":"K Kielsen","year":"2015","unstructured":"Kielsen K, Jordan KK, Uhlving HH, Pontoppidan PL, Shamim Z, Ifversen M, et al. T cell reconstitution in allogeneic haematopoietic stem cell transplantation: prognostic significance of plasma interleukin-7. Scand J Immunol. 2015;81:72\u201380. \n                    https:\/\/doi.org\/10.1111\/sji.12244","journal-title":"Scand J Immunol"},{"key":"426_CR28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.imbio.2017.10.023","volume":"223","author":"K Kielsen","year":"2018","unstructured":"Kielsen K, Ryder LP, Lennox-hvenekilde D, Gad M, Nielsen CH, Heilmann C, et al. Immunobiology reconstitution of Th17, Tc17 and Treg cells after paediatric haematopoietic stem cell transplantation: Impact of interleukin-7. Immunobiology. 2018;223:220\u20136. \n                    https:\/\/doi.org\/10.1016\/j.imbio.2017.10.023","journal-title":"Immunobiology"},{"key":"426_CR29","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.bbmt.2017.03.021","volume":"23","author":"K Jordan","year":"2017","unstructured":"Jordan K, Pontoppidan P, Uhlving HH, Kielsen K, Burrin DG, Weischendorff S, et al. Biology of blood and marrow transplantation gastrointestinal toxicity, systemic inflammation, and liver biochemistry in allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2017;23:1170\u20136. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2017.03.021","journal-title":"Biol Blood Marrow Transplant"},{"key":"426_CR30","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.intimp.2014.12.038","volume":"25","author":"PL Pontoppidan","year":"2015","unstructured":"Pontoppidan PL, Jordan K, Carlsen AL, Uhlving H, Kielsen K, Christensen M, et al. International Immunopharmacology Associations between gastrointestinal toxicity, micro RNA and cytokine production in patients undergoing myeloablative allogeneic stem cell transplantation. Int Immunopharmacol. 2015;25:180\u20138. \n                    https:\/\/doi.org\/10.1016\/j.intimp.2014.12.038","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"426_CR31","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/ki.2012.169","volume":"82","author":"George J. Schwartz","year":"2012","unstructured":"Schwartz GJ, Schneider MF, Maier PS, Moxey-Mims M, Dharnidharka VR, Warady BA, et al. Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C. Kidney Int. 2012;82:445\u201353. \n                    https:\/\/doi.org\/10.1038\/ki.2012.169\n                    \n                  .","journal-title":"Kidney International"},{"issue":"3","key":"426_CR32","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"George J. Schwartz","year":"2009","unstructured":"Schwartz GJ, Mun A, Schneider MF, Mak RH, Kaskel F, Warady BA, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20:629\u201337. \n                    https:\/\/doi.org\/10.1681\/ASN.2008030287\n                    \n                  .","journal-title":"Journal of the American Society of Nephrology"},{"key":"426_CR33","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1186\/s12879-017-2913-8","volume":"17","author":"Y Xing","year":"2017","unstructured":"Xing Y, Chen L, Feng Y, Zhou Y, Zhai Y, Lu J. Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections. BMC Infect Dis. 2017;17:798. \n                    https:\/\/doi.org\/10.1186\/s12879-017-2913-8","journal-title":"BMC Infect Dis"},{"key":"426_CR34","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1080\/14740338.2018.1462334","volume":"17","author":"KZ Vardakas","year":"2018","unstructured":"Vardakas KZ, Kalimeris GD, Triarides NA, Falagas ME. An update on adverse drug reactions related to \u03b2-lactam antibiotics. Expert Opin Drug Saf. 2018;17:499\u2013508. \n                    https:\/\/doi.org\/10.1080\/14740338.2018.1462334","journal-title":"Expert Opin Drug Saf"},{"key":"426_CR35","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s12185-014-1578-y","volume":"99","author":"N Maximova","year":"2014","unstructured":"Maximova N, Ferrara G, Minute M, Pizzol A, Kiren V, Montico M, et al. Experience from a single paediatric transplant centre with identification of some protective and risk factors concerning the development of hepatic veno-occlusive disease in children after allogeneic hematopoietic stem cell transplant. Int J Hematol. 2014;99:766\u201372. \n                    https:\/\/doi.org\/10.1007\/s12185-014-1578-y","journal-title":"Int J Hematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0426-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0426-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0426-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:13:48Z","timestamp":1684617228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-018-0426-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,25]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["426"],"URL":"https:\/\/doi.org\/10.1038\/s41409-018-0426-8","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,25]]},"assertion":[{"value":"16 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}